Cammà C - Search Results

1

Vizzutti F, Celsa C, Battaglia S, Miraglia R, Enea M, Marra F, Colecchia A, Cammà C, Schepis F. Vizzutti F, et al. Among authors: camma c. Hepatology. 2023 Mar 1;77(3):E57-E58. doi: 10.1002/hep.32784. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36098577 No abstract available.

2

When and how to treat acute hepatitis C?

Licata A, Di Bona D, Schepis F, Shahied L, Craxí A, Cammà C. Licata A, et al. Among authors: camma c. J Hepatol. 2003 Dec;39(6):1056-62. doi: 10.1016/s0168-8278(03)00461-6. J Hepatol. 2003. PMID: 14642626

3

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Cammà C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, Craxì A. Cammà C, et al. Hepatology. 2004 Feb;39(2):333-42. doi: 10.1002/hep.20073. Hepatology. 2004. PMID: 14767986

4

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Manno M, Cammà C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E. Manno M, et al. Among authors: camma c. Gastroenterology. 2004 Sep;127(3):756-63. doi: 10.1053/j.gastro.2004.06.021. Gastroenterology. 2004. PMID: 15362032

5

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

Salerno F, Cammà C, Enea M, Rössle M, Wong F. Salerno F, et al. Among authors: camma c. Gastroenterology. 2007 Sep;133(3):825-34. doi: 10.1053/j.gastro.2007.06.020. Epub 2007 Jun 20. Gastroenterology. 2007. PMID: 17678653

6

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.

Cammà C, Cabibbo G, Bronte F, Enea M, Licata A, Attanasio M, Andriulli A, Craxì A. Cammà C, et al. J Hepatol. 2009 Oct;51(4):675-81. doi: 10.1016/j.jhep.2009.06.018. Epub 2009 Jul 15. J Hepatol. 2009. PMID: 19665247

7

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.

Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, Cammà C. Cabibbo G, et al. Among authors: camma c. Hepatology. 2010 Apr;51(4):1274-83. doi: 10.1002/hep.23485. Hepatology. 2010. PMID: 20112254

8

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C.

Cammà C, Petta S, Enea M, Bruno R, Bronte F, Capursi V, Cicchetti A, Colombo GL, Di Marco V, Gasbarrini A, Craxì A; WEF Study Group. Cammà C, et al. Hepatology. 2012 Sep;56(3):850-60. doi: 10.1002/hep.25734. Epub 2012 Jul 12. Hepatology. 2012. PMID: 22454336

9

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma.

Cammà C, Cabibbo G, Petta S, Enea M, Iavarone M, Grieco A, Gasbarrini A, Villa E, Zavaglia C, Bruno R, Colombo M, Craxì A; WEF study group; SOFIA study group. Cammà C, et al. Hepatology. 2013 Mar;57(3):1046-54. doi: 10.1002/hep.26221. Epub 2013 Feb 12. Hepatology. 2013. PMID: 23299720

10

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.

Cammà C, Petta S, Cabibbo G, Ruggeri M, Enea M, Bruno R, Capursi V, Gasbarrini A, Alberti A, Craxì A; WEF Study Group. Cammà C, et al. J Hepatol. 2013 Oct;59(4):658-66. doi: 10.1016/j.jhep.2013.05.019. Epub 2013 May 23. J Hepatol. 2013. PMID: 23707373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters